Article
KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.
Diabetes - 1 Oct 2003
van der Slik Arno R, Koeleman Bobby P C, Verduijn Willem, Bruining G Jan, Roep Bart O, Giphart Marius J
Abstract excerpt
Killer cell immunoglobulin-like receptors (KIRs) modulate natural killer cell and T-cell function by interacting with HLA class 1 ligands on target cells. Both KIR and HLA are highly polymorphic. We studied the influence of KIR and HLA class 1 genes on the susceptibility to develop type 1 diabetes. The results showed increased numbers of activating KIR genes in patients compared with control subjects (P = 0.049)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
